Triad Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Triad Wealth Partners's PFE Position: Q3 2026 in Review
Triad Wealth Partners reduced its Pfizer (PFE) stake by 20% in Q3 2026, selling an estimated $98.4K and leaving 15,222 shares worth $434K. The position accounts for 0.02% of the portfolio, ranked #353.
Triad Wealth Partners first reported a position in PFE in Q2 2024 and has held it in 7 quarters since. The position peaked at $512K in Q3 2025. 2,915 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Triad Wealth Partners held 15,222 shares of Pfizer worth $434K as of Q3 2026.
- Triad Wealth Partners sold 3,701 Pfizer shares in Q3 2026, an estimated $98.4K.
- Pfizer made up 0.02% of Triad Wealth Partners's portfolio in Q3 2026, its #353 holding.
- Triad Wealth Partners first reported a position in Pfizer in Q2 2024 and has held it in 7 quarters since.
- Triad Wealth Partners's Pfizer position peaked at $512K in Q3 2025.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Triad Wealth Partners's 13F filing for Q3 2026, filed 26 Oct 2026.